Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medius Holdings CoTSE:3154 -1.96%57 Return-on-Tangible-Equity is 19.38% as of Mar. 2026, which is 142% above its 10-year median of 8.00. GuruFocus rates TSE:3154 with a GF Score™ of 57/100 and a GF Value™ of 円981.49 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 756 Medical Devices & Instruments companies, Medius Holdings Co ranks better than 51.46% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Medius Holdings Co's annualized net income for the quarter that ended in Mar. 2026 was 円3,580 Mil. Medius Holdings Co's average shareholder tangible equity for the quarter that ended in Mar. 2026 was 円18,469 Mil. Therefore, Medius Holdings Co's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 19.38%.
The historical rank and industry rank for Medius Holdings Co's Return-on-Tangible-Equity or its related term are showing as below:
TSE:3154'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -0.63 Med: 8 Max: 16.42
Current: 5.14
During the past 13 years, Medius Holdings Co's highest Return-on-Tangible-Equity was 16.42%. The lowest was -0.63%. And the median was 8.00%.
TSE:3154's Return-on-Tangible-Equity is ranked better than 51.46% of 756
companies
in the Medical Devices & Instruments industry
Industry Median: 4.855
vs TSE:3154: 5.14
Medius Holdings Co (TSE:3154) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Medius Holdings Co Return-on-Tangible-Equity Related Terms
Medius Holdings Co Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Medius Holdings Co's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medius Holdings Co Return-on-Tangible-Equity Chart
TSE:3154 vs ISRG, BDX, MDLN: Return-on-Tangible-Equity Comparison
For the Medical Instruments & Supplies subindustry, Medius Holdings Co's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medius Holdings Co Return-on-Tangible-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medius Holdings Co's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Medius Holdings Co's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 19.38% mean?
Medius Holdings Co (TSE:3154) has a Return-on-Tangible-Equity of 19.38% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Medius Holdings Co and its competitors. This is 142% above median its historical median of 8.00. According to the industry distribution chart, Medius Holdings Co ranks #367 out of 756 companies in the Medical Devices & Instruments industry, placing it in the top 48.5%.
Is Medius Holdings Co's Return-on-Tangible-Equity too high?
Medius Holdings Co's current Return-on-Tangible-Equity of 19.38% is 142% above median its 10-year median of 8.00. The Medical Devices & Instruments industry median Return-on-Tangible-Equity is 4.86. Medius Holdings Co's value of 19.38% is 299.2% above this industry median. Based on the distribution chart, Medius Holdings Co ranks #367 out of 756 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Medius Holdings Co has a GF Score™ of 57/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medius Holdings Co's Return-on-Tangible-Equity compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Medius Holdings Co ranks #367 out of 756 companies for Return-on-Tangible-Equity. This puts Medius Holdings Co in the upper half of its industry. The industry median Return-on-Tangible-Equity is 4.86. Medius Holdings Co's value of 19.38% is 299.2% above this benchmark. While the company's 10-year median is 8.00 vs. the industry median of 4.86, Medius Holdings Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Devices & Instruments company?
The median Return-on-Tangible-Equity among Medical Devices & Instruments companies is 4.86, based on 756 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medius Holdings Co's current Return-on-Tangible-Equity of 19.38% is 299.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Medius Holdings Co and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Equity is 4.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medius Holdings Co's current Return-on-Tangible-Equity is 19.38%, which is 142% above median its own 10-year median of 8.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medius Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Medius Holdings Co (TSE:3154) is currently considered Modestly Undervalued. The stock's GF Value™ is 円981.49, compared to a current price of 円800.00 — trading 18.5% below its estimated fair value. The current Return-on-Tangible-Equity is 19.38%, which is 142% above median its 10-year median of 8.00 and 299.2% above the Medical Devices & Instruments industry median of 4.86. Medius Holdings Co's overall GF Score™ is 57/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Medius Holdings Co (TSE:3154), the current Return-on-Tangible-Equity is 19.38% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medius Holdings Co (TSE:3154) Overvalued in 2026?
Based on GuruFocus' analysis, Medius Holdings Co stock appears to be undervalued.
The current stock price of 円800.00 is trading 18.5% below its estimated GF Value™ of 円981.49.
GuruFocus considers Medius Holdings Co to be Modestly Undervalued.
Key valuation signals for TSE:3154:
Return-on-Tangible-Equity: 19.38% (142% above median its 10-year median of 8.00)
GF Value™: 円981.49 vs. price of 円800.00 (18.5% below fair value)
Industry Position: 299.2% above the Medical Devices & Instruments median (#367 of 756)
No single metric tells the full story. See the TSE:3154 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medius Holdings Co Ltd is engaged in the healthcare sector. The company's business division includes Medical equipment sales business, Care and welfare business, and Solution business. The Medical equipment sales business offers syringes and gloves to surgical assistance along with repairs and maintenance of medical equipment, and The care and welfare business provides transfer equipment and electric powdered beds. The company's segments include: Medical equipment sales business; and Nursing care and welfare business. It derives maximum revenue from Medical equipment sales business.
57GF Score
Get the complete analysis for TSE:3154
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3154 has been successfully added to your 
